- Home
- PCRX vs ODC Comparison
PCRX vs ODC Comparison
Compare PCRX & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- ODC
- Stock Information
- Founded
- PCRX 2006
- ODC 1941
- Country
- PCRX United States
- ODC United States
- Employees
- PCRX N/A
- ODC N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- ODC Miscellaneous manufacturing industries
- Sector
- PCRX Health Care
- ODC Consumer Discretionary
- Exchange
- PCRX Nasdaq
- ODC Nasdaq
- Market Cap
- PCRX 604.7M
- ODC 310.1M
- IPO Year
- PCRX 2011
- ODC N/A
- Fundamental
- Price
- PCRX $22.84
- ODC $43.71
- Analyst Decision
- PCRX Buy
- ODC
- Analyst Count
- PCRX 10
- ODC 0
- Target Price
- PCRX $27.60
- ODC N/A
- AVG Volume (30 Days)
- PCRX 787.3K
- ODC 36.3K
- Earning Date
- PCRX 02-27-2025
- ODC 03-06-2025
- Dividend Yield
- PCRX N/A
- ODC 1.44%
- EPS Growth
- PCRX N/A
- ODC 36.22
- EPS
- PCRX N/A
- ODC 3.09
- Revenue
- PCRX $694,957,000.00
- ODC $454,094,000.00
- Revenue This Year
- PCRX $4.83
- ODC N/A
- Revenue Next Year
- PCRX $2.16
- ODC N/A
- P/E Ratio
- PCRX N/A
- ODC $13.78
- Revenue Growth
- PCRX 4.40
- ODC 6.61
- 52 Week Low
- PCRX $11.16
- ODC $29.48
- 52 Week High
- PCRX $34.01
- ODC $46.50
- Technical
- Relative Strength Index (RSI)
- PCRX 72.97
- ODC 59.87
- Support Level
- PCRX $18.18
- ODC $42.18
- Resistance Level
- PCRX $22.36
- ODC $42.45
- Average True Range (ATR)
- PCRX 1.17
- ODC 1.23
- MACD
- PCRX 0.33
- ODC -0.22
- Stochastic Oscillator
- PCRX 99.15
- ODC 74.57
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.